Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Michael C. Swett"'
Autor:
Ivan Urits, Daniel Swanson, Michael C. Swett, Anjana Patel, Kevin Berardino, Ariunzaya Amgalan, Amnon A. Berger, Hisham Kassem, Alan D. Kaye, Omar Viswanath
Publikováno v:
Neurology and Therapy, Vol 9, Iss 2, Pp 301-315 (2020)
Abstract Hereditary variant transthyretin amyloidosis (ATTRv) is a rare genetic defect that affects about 5000–10,000 people worldwide, causing amyloidosis secondary to misfolding of mutant transthyretin (TTR) protein fibrils. TTR mutations can cau
Externí odkaz:
https://doaj.org/article/d4411de9a7a947deab62328df510341a
Autor:
Omar Viswanath, Amnon A Berger, Elyse M. Cornett, Michael C Swett, Ivan Urits, Melis Yilmaz, Karina Charipova, Hisham Kassem, Ehab Bahrum, Anh L. Ngo, Alan D. Kaye, Kyle Gress
Publikováno v:
Neurology and Therapy
Neurology and Therapy, Vol 9, Iss 2, Pp 403-417 (2020)
Neurology and Therapy, Vol 9, Iss 2, Pp 403-417 (2020)
Purpose of Review This is a comprehensive review of the current literature on the usage of galcanezumab for migraine treatment. It reviews the biology, pathophysiology, epidemiology, diagnosis, and conventional treatment of migraines, then compares t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff9ddf4ff297487195a6edcb06dd907e
https://doi.org/10.1007/s40120-020-00214-3
https://doi.org/10.1007/s40120-020-00214-3
Autor:
Omar Viswanath, Hisham Kassem, Alan D. Kaye, Daniel Swanson, Anjana Patel, Michael C Swett, Ariunzaya Amgalan, Ivan Urits, Amnon A Berger, Kevin Berardino
Publikováno v:
Neurology and Therapy
Neurology and Therapy, Vol 9, Iss 2, Pp 301-315 (2020)
Neurology and Therapy, Vol 9, Iss 2, Pp 301-315 (2020)
Hereditary variant transthyretin amyloidosis (ATTRv) is a rare genetic defect that affects about 5000–10,000 people worldwide, causing amyloidosis secondary to misfolding of mutant transthyretin (TTR) protein fibrils. TTR mutations can cause protei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e61701f432dddc09bce74fff535eaed
http://europepmc.org/articles/PMC7606409
http://europepmc.org/articles/PMC7606409
Autor:
Omar Viswanath, Hisham Kassem, Daniel Swanson, Ariunzaya Amgalan, Alan D. Kaye, Ivan Urits, Amnon A Berger, Kevin Berardino, Anjana Patel, Michael C Swett
Publikováno v:
Neurology and Therapy
Hereditary variant transthyretin amyloidosis (ATTRv) is a rare genetic defect that affects about 5000-10,000 people worldwide, causing amyloidosis secondary to misfolding of mutant transthyretin (TTR) protein fibrils. TTR mutations can cause protein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e24edfa684ae10330602c8058d4eba5
https://doi.org/10.1007/s40120-020-00228-x
https://doi.org/10.1007/s40120-020-00228-x